Stocktoria
HeartBeam, Inc. BEATW
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
HeartBeam, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $13.4M | $11.1M | $6.8M | $5.7M | $255,000 |
| Operating income | -$21.1M | -$19.9M | -$15.3M | -$13.0M | -$2.3M |
| Interest expense | — | — | — | — | $2.2M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$21.0M | -$19.4M | -$14.6M | -$13.0M | -$4.4M |
| EPS (diluted) | $-0.62 | $-0.73 | $-0.72 | $-1.59 | $-1.03 |
| Operating cash flow | -$14.0M | -$14.5M | -$12.1M | -$9.9M | -$3.2M |
| Free cash flow | -$14.6M | -$14.7M | -$12.3M | -$9.9M | — |
| Cash & equivalents | $4.4M | $2.4M | $16.2M | $3.6M | $13.2M |
| Inventory | $103,000 | $0 | — | — | — |
| Total assets | $5.8M | $3.3M | $17.1M | $4.0M | $14.0M |
| Total liabilities | $3.2M | $1.6M | $1.2M | $1.7M | $588,000 |
| Shareholders' equity | $2.6M | $1.7M | $15.9M | $2.4M | $13.4M |
Source: SEC EDGAR filings · CIK 0001779372 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.